Clinical Trial LCC0418 Phase II
 

This trial is only done at Chapel Hill only. The're going to take out my dendritic cells and incubate them with tumor cells that overexpress Her-2/neu. It wil make my dendtric cells smarter then make a vaccine out of it.

They will add the vacinne and Vinorelbine to my currnent treatment. (Herceptin, Tykerb and Zometa

I would like to hear from those that have been thru this trial or if you knew someone..

email: chenry5@ec.rr.com

Re: Clinical Trial LCC0418 Phase II
 

I am not on this therapy but I'm actually a PhD in Immunology and stage IV breast cancer warrior myself- and can say that it is great that you are enrolling in this therapy. I've studied dendritic cells in my research and I know for a fact that this therapy has a lot of potential. It would be a great break through if it can help in breast cancer, I will pray that those little dendritic cells get fully primed against those nasty cancer antigens and then they go on to kill the cells in your body.

As a former researcher myself (I left science to spend time home with my family), it brings me such joy to know that there are people like you out there to help test and prove that immunotherapy is a valuable tool in the fight against cancer.
Huggs!